ABSTRACT The relationship between 3-hydroxy-3-methylglutaryl (HMG) CoA hibitor compactin, the normal S-phase burst of DNA synthesis was specifically and totally prevented. Finally, the compactin-induced inhibition of DNA synthesis could be completely reversed within minutes by the addition of mevalonate, the product of the HMG CoA reductase reaction. By contrast, addition of cholesterol-rich lipoproteins had no effect upon DNA synthesis in compactin-treated cells. These data demonstrate that HMG CoA reductase activity, and therefore the production of mevalonate, plays an essential role in the synthesis of DNA specifically during the S phase of the cell cycle. Moreover, the results indicate that this function of mevalonate in regulating DNA replication is independent of its conversion to cholesterol.
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A large body of evidence has accumulated indicating that de novo cholesterogenesis plays an important role in cell growth. Except in a tissue such as liver, which secretes cholesterol into the bloodstream, there is a well-documented correlation between the activity of hydroxymethylglutaryl (HMG) CoA reductase [mevalonate:NADP+ oxidoreductase (CoA-acylating), EC 1.1.1.34] and cell replication. Rapidly proliferating tissues, such as intestine and developing brain, demonstrate high rates of cholesterol synthesis and increased activities of HMG CoA reductase, the rate-limiting enzyme and the source of mevalonate, on the pathway of cholesterogenesis (1) (2) (3) (4) . By contrast, adult brain and kidney, which have very slow cell turnover, have low rates of de novo cholesterogenesis and little HMG CoA reductase activity (2, 3, 5) . Moreover, adult tissues that are stimulated to divide, such as regenerating liver (6) or phytohemagglutinin-treated lymphocytes (7) , develop both increased HMG CoA reductase activity and accelerated overall cholesterol synthesis. It is also a consistent characteristic of both malignant (6, (8) (9) (10) (11) (12) and premalignant (10) cells that they lose the feedback regulation of HMG CoA reductase and of cholesterogenesis which characterizes normal tissues.
Furthermore, there are ample data indicating that the role in cell growth played by the cholesterol synthetic pathway may be an essential one. Several studies have demonstrated that if HMG CoA reductase activity is blocked-for 1-3 days in mammalian cells in tissue culture, cell growth (13) and DNA synthesis (14, 15) Cholesterol. Cholesterol was determined by gas/liquid chromatography by means of an OV-17 column and a Hewlett-Packard (model 5830A) gas/liquid chromatograph.
Cell Number. At the time intervals noted, cells were scraped from the petri dishes with a rubber policeman and diluted in 1 ml of phosphate-buffered saline. An aliquot of 20,l was added to 20 Ml of 0.1% trypan blue and the cells were counted in a hemocytometer.
Autoradiography. Synchronized monolayers were grown on two-chamber slides. When the dThd block was released, cells were washed as described before and fixed in Carnoy's fixative, dehydrated, and dried overnight. Autoradiography was carried out for 12 days.
RESULTS
Thymidine Incorporation into DNA During BHK-21 Cell Cycle. Fig. 1 , from 5% to 80%) over the 3-hr period after block release, followed by a decrease to a minimum labeled cell number of 10% between 8 and 12 hr after block release.
As indicated in Fig. 1 , the total number of cells doubled between 10 and 12 hr after the dThd block was removed; this time corresponds to a cell cycle of 12.5 hr, a figure which agrees with that previously reported for BHK-21 cells grown at 37°C (25) .
At the time that the dThd block was released, the BHK cells typically appeared extended and flat, their normal appearance Biochemistry: Quesney-Huneeus et al. It is striking that the HMG CoA reductase activity consistently increased and reached a maximum just prior to or at the time that S-phase dThd incorporation into DNA increased to its maximum. This effect was seen more clearly in the second S-phase peak of the two cell cycles studied, where the maximum HMG CoA reductase activity always preceded the S-phase burst (19, 27, 28) . In preliminary studies it was shown that at a compactin concentration of 2.5 ,uM, sterol synthesis in the BHK-21 cell line was inhibited over a 1-hr period by at least 95%. This inhibition of cholesterol synthesis was sustained as long as compactin was present in the medium.
As shown in Fig. 2 , when compactin (2.5 MtM) was added to synchronized BHK-21 cells 1 hr prior to assay for DNA synthesis, the S-phase burst of DNA synthesis was completely prevented. This effect, moreover, was observed for each of the two cell cycles studied and in each of a total of three experiments.
Initial evidence for the specificity of the compactin inhibition of DNA synthesis was provided by the fact that throughout the 13 hr of the experiment, the compactin-treated BHK-21 cells remained morphologically normal, adhered to the surface of the tissue culture dishes, and consistently showed exclusion of trypan blue in at least 95% of the cells. Moreover, the 1-hr compactin treatment caused no change in total cell numbers at any time during the cell cycle.
Mevalonate Reversal of Blocked DNA Synthesis. That the effect of compactin on DNA synthesis was due specifically to an inhibition of mevalonate production was demonstrated by the fact (Fig. 2) Effect of Cholesterol and Mevalonate on CompactinInduced Inhibition of DNA Synthesis in Cells Grown in Delipidized Serum. Because the experiment described in Fig.  2 was carried out in the presence of the relatively high concentrations of cholesterol normally present in whole serum, it seemed unlikely that the compactin-induced inhibition of DNA synthesis could be the result of decreasing the cholesterol content of the cell. Direct measurement of the cholesterol content of the BHK-21 cells in fact confirmed that a 2-hr exposure to compactin had no detectable effect upon their cholesterol content (i.e., control, 17 ug/106 cells; compactin, 19 ,g/106 cells). This possibility was more directly examined by repeating the study with BHK-21 cells grown in medium containing delipidized serum. As shown in Fig. 3 , inhibition of HMG CoA reductase activity by the addition of compactin once more resulted in complete elimination of S-phase DNA synthesis in both of the cell cycles examined during this experiment. Mevalonic acid, when added for the last 15 min of each experimental period, again caused a complete reversal of the compactin-induced inhibition of DNA synthesis during the first cell cycle studied; even more dramatically, during the second S phase the addition of mevalonic acid not only reversed the compactin inhibition, but resulted in an acceleration of DNA synthesis to a level of approximately twice that of the untreated control cells.
In marked contrast to the striking effect of mevalonic acid on DNA synthesis, the addition of cholesterol-rich lipoproteins, despite causing the cholesterol content of the cells to increase by 64%, was completely incapable of reversing the compactin inhibition of S-phase DNA synthesis.
This experiment indicates that the HMG CoA reductase requirement for DNA synthesis is the result of a dependence of S-phase DNA production upon the availability of mevalonic acid itself rather than on any increment of cholesterol that might have resulted from increased mevalonate synthesis.
Specificity of Mevalonate-Induced DNA Synthesis for S-Phase DNA. It is apparent from the data in Figs. 2 and 3 that the effect of compactin is remarkably specific for the S-phase burst of DNA synthesis in that the compactin block of meva- Figs. 2 and 3 , addition of mevalonate affected DNA synthesis only during the S phase of the cycle. DISCUSSION The major finding of the present study is that mevalonate, or a product of mevalonate, is essential for the initiation of DNA replication, specifically during the S phase of the cell cycle. The first indication in this study that mevalonate production might play a role in DNA synthesis was the finding that in synchronized cultures of BHK-21 cells, HMG CoA reductase activity and, hence, mevalonate synthesis regularly increase at or just prior to the S-phase acceleration of DNA synthesis. This finding raised the possibility that HMG CoA reductase might play some role in initiating or controlling DNA synthesis in the normal cell cycle. This hypothesis was strengthened by the observation that when HMG CoA reductase was blocked by the competitive inhibitor, compactin, the S-phase burst of DNA synthesis was completely inhibited, an observation which indicated that the presence of mevalonate might well be required for DNA synthesis. That the effect of compactin in blocking DNA synthesis was in fact mediated through an inhibition of mevalonate production was then directly demonstrated by the finding that the compactin-induced inhibition of S-phase DNA synthesis was completely reversed within minutes after the addition of mevalonate. In fact, the addition of relatively large amounts of mevalonate to the compactin-blocked cells stimulated DNA synthesis even to levels well above those of the control cell population.
Several lines of evidence indicate that the requirement for mevalonate production in S-phase DNA synthesis is independent of its conversion to cholesterol. First, cells incubated in Biochemistry: Quesney-Huneeus et at. media containing whole serum were exposed to cholesterol concentrations of 4.1 mg/dl, a level that has been shown to be adequate to supply the cellular cholesterol requirements in tissue culture (21) and that permitted growth to confluence in the present experiments. Despite the presence of such ample amounts of cholesterol, blockage of mevalonate synthesis for only 1 hr completely prevented DNA replication. No detectable depletion of cellular cholesterol occurred during this brief exposure to compactin. On the other hand, the restoration of Sphase DNA synthesis was observed within minutes after addition of mevalonate, during which time only picomole amounts of mevalonate were incorporated into a cellular cholesterol pool of more than 30 nmol. Finally, when cells were grown in media containing delipidized plasma, mevalonate promptly reversed the compactin-induced block of DNA synthesis, whereas the addition of relatively large concentrations of cholesterol in the form of cholesterol-rich lipoproteins, while increasing the cholesterol concentration in the cell by 64%, was totally ineffective in reversing the inhibition of DNA synthesis. Thus, it would appear that either mevalonate itself or an isoprenoid product of mevalonate stimulates S-phase DNA synthesis by a mechanism that is independent of its role in sterol synthesis.
The effect of mevalonate on DNA synthesis appears to be specific for the DNA replication that takes place in the S phase of the cell cycle. The data in Figs. 2 and 3 clearly demonstrate that treatment with compactin blocks DNA synthesis only at this phase of the cell cycle and has no effect upon the residual DNA synthesis of G2, M, and GI phases. In addition, treatment with mevalonate did not significantly enhance DNA synthesis during any but the S phase of the cycle. This surprising specificity of the mevalonate effect for this phase of DNA synthesis suggests that mevalonate, or a derivative, may be required for the activation of DNA polymerase, in all likelihood the a-DNA polymerase, which functions specifically during the S phase of the cell cycle to effect the replication of the DNA chain (29, 30) . In this regard, any possible effect of mevalonate on the earlier steps of DNA synthesis [e.g., on thymidine kinase, which shows maximum activity at the G2 phase of the cell cycle (31)] would have been reflected in the DNA synthesis at G2, M, and GI phases, which, as noted, were in fact not influenced by the availability of mevalonate.
HMG CoA reductase, then, probably has at least two independent roles in regulating cell division. First, as is well established, the mevalonate produced by this enzyme can, if necessary, provide adequate amounts of cholesterol for the longterm maintenance of plasma membrane integrity. Second, as demonstrated in the present study, mevalonate, either itself or perhaps through some intermediate product, appears to be required for the very rapid activation of DNA polymerasecatalyzed DNA replication. In fact, as shown here, not only does the absence of mevalonate prevent normal, S-phase DNA synthesis, but an excess of mevalonate can, within a few minutes, stimulate DNA replication to supernormal levels.
Although the exact chemical structure of the mevalonatederived stimulator of DNA synthesis remains to be established, the unexpected finding that the activity of HMG CoA reductase and, hence, mevalonate production play essential regulatory roles in S-phase DNA synthesis indicates an important functional link between these two apparently unrelated biochemical processes. Moreover, these findings, coupled with our earlier observation that the feedback control of this enzyme is consistently and uniquely lost during the uncontrolled cell growth of malignant states (6, (8) (9) (10) (11) , suggest that HMG CoA reductase may have far more important physiologic and pathologic functions in normal and deranged cell replication than has heretofore been suspected.
